These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 16126868
1. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus. Yamazaki K, Hasegawa M, Ohoka I, Hanami K, Asoh A, Nagao T, Sugano I, Ishida Y. J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868 [Abstract] [Full Text] [Related]
2. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. Evangelou K, Kotsinas A, Mariolis-Sapsakos T, Giannopoulos A, Tsantoulis PK, Constantinides C, Troupis TG, Salmas M, Kyroudis A, Kittas C, Gorgoulis VG. J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803 [Abstract] [Full Text] [Related]
3. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL. Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3705-11. PubMed ID: 14506162 [Abstract] [Full Text] [Related]
4. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. Zacharatos P, Kotsinas A, Evangelou K, Karakaidos P, Vassiliou LV, Rezaei N, Kyroudi A, Kittas C, Patsouris E, Papavassiliou AG, Gorgoulis VG. J Pathol; 2004 Jul 01; 203(3):744-53. PubMed ID: 15221933 [Abstract] [Full Text] [Related]
5. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis. Rakha EA, Pinder SE, Paish EC, Robertson JF, Ellis IO. J Pathol; 2004 Jul 01; 203(3):754-61. PubMed ID: 15221934 [Abstract] [Full Text] [Related]
6. E2F-1: a proliferative marker of breast neoplasia. Zhang SY, Liu SC, Al-Saleem LF, Holloran D, Babb J, Guo X, Klein-Szanto AJ. Cancer Epidemiol Biomarkers Prev; 2000 Apr 01; 9(4):395-401. PubMed ID: 10794484 [Abstract] [Full Text] [Related]
7. E2F-1 transcription factor is overexpressed in oxyphilic thyroid tumors. Volante M, Croce S, Pecchioni C, Papotti M. Mod Pathol; 2002 Oct 01; 15(10):1038-43. PubMed ID: 12379749 [Abstract] [Full Text] [Related]
8. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system. Tokman B, Gultekin SE, Sezer C, Alpar R. Saudi Med J; 2004 Dec 01; 25(12):1922-30. PubMed ID: 15711668 [Abstract] [Full Text] [Related]
9. Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Faried A, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H. Eur J Cancer; 2004 Dec 01; 40(18):2804-11. PubMed ID: 15571964 [Abstract] [Full Text] [Related]
11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E. Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860 [Abstract] [Full Text] [Related]
13. Bag-1 expression as a prognostic factor in tongue squamous cell carcinomas. Xie X, Clausen OP, Boysen M. Laryngoscope; 2004 Oct 01; 114(10):1785-90. PubMed ID: 15454773 [Abstract] [Full Text] [Related]
14. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Kwong RA, Kalish LH, Nguyen TV, Kench JG, Bova RJ, Cole IE, Musgrove EA, Sutherland RL. Clin Cancer Res; 2005 Jun 01; 11(11):4107-16. PubMed ID: 15930346 [Abstract] [Full Text] [Related]
15. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma. Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y. Acta Otolaryngol; 2005 Jul 01; 125(7):779-85. PubMed ID: 16012042 [Abstract] [Full Text] [Related]
16. E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Bramis J, Zacharatos P, Papaconstantinou I, Kotsinas A, Sigala F, Korkolis DP, Nikiteas N, Pazaiti A, Kittas C, Bastounis E, Gorgoulis VG. Anticancer Res; 2004 Jul 01; 24(5A):3041-7. PubMed ID: 15517914 [Abstract] [Full Text] [Related]
17. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865 [Abstract] [Full Text] [Related]
18. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Zhang SY, Liu SC, Johnson DG, Klein-Szanto AJ. Cancer Res; 2000 Nov 01; 60(21):5972-6. PubMed ID: 11085515 [Abstract] [Full Text] [Related]
19. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma. Gasinska A, Urbanski K, Gruchala A, Biesaga B, Kojs Z. Neoplasma; 2002 Nov 01; 49(6):379-86. PubMed ID: 12584585 [Abstract] [Full Text] [Related]
20. Apaf-1 is a transcriptional target for E2F and p53. Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Müller H, Helin K. Nat Cell Biol; 2001 Jun 01; 3(6):552-8. PubMed ID: 11389439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]